Rua Bioscience (NZSE:RUA) EPS (Basic): NZ$-0.02 (TTM As of Dec. 2025)


What is Rua Bioscience EPS (Basic)?

Rua Bioscience NZSE:RUA EPS (Basic) is NZ$-0.02 as of Dec. 2025. The stock has 4 warning signs investors should review.

Rua Bioscience's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NZ$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NZ$-0.02.

Rua Bioscience's EPS (Diluted) for the six months ended in Dec. 2025 was NZ$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NZ$-0.02.

Rua Bioscience's EPS without NRI for the six months ended in Dec. 2025 was NZ$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.02.

During the past 3 years, the average EPS without NRI Growth Rate was 27.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Rua Bioscience's highest 3-Year average EPS without NRI Growth Rate was 27.10% per year. The lowest was 5.70% per year. And the median was 16.40% per year.

Rua Bioscience  (NZSE:RUA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Rua Bioscience EPS (Basic) Related Terms

Rua Bioscience EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience EPS (Basic) Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
EPS (Basic)
-0.03 -0.05 -0.03 -0.07 -0.02

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.06 -0.02 -0.01 -0.01 -0.01

Rua Bioscience EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Rua Bioscience's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.456-0)/177.539
=-0.02

Rua Bioscience's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.793-0)/298.905
=-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NZ$-0.02 mean?
Rua Bioscience (NZSE:RUA) has a EPS (Basic) of NZ$-0.02 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Rua Bioscience and its competitors.
Is Rua Bioscience's EPS (Basic) too high?
Rua Bioscience's current EPS (Basic) is NZ$-0.02.
How does Rua Bioscience's EPS (Basic) compare to ZTS and UTHR?
Rua Bioscience's EPS (Basic) of NZ$-0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Rua Bioscience and its competitors. Rua Bioscience's current EPS (Basic) is NZ$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current EPS (Basic) of NZ$-0.02. The current EPS (Basic) is NZ$-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current EPS (Basic) is NZ$-0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.